European Union - Italian - EMA (European Medicines Agency)

novo nordisk a/s - insulina degludec - diabete mellito - farmaci usati nel diabete - trattamento del diabete mellito negli adulti.

European Union - Italian - EMA (European Medicines Agency)

novo nordisk a/s - semaglutide - obesity; overweight - preparazioni antiobesità, escl. prodotti dietetici - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - soluzione iniettabile in penna preriempita - semaglutidum 0.25 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.078557 mmol. - gewichtsregulierung - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - soluzione iniettabile in penna preriempita - semaglutidum 0.5 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.078557 mmol. - gewichtsregulierung - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - soluzione iniettabile in penna preriempita - semaglutidum 1 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.078557 mmol. - gewichtsregulierung - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - soluzione iniettabile in penna preriempita - semaglutidum 1.7 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 0.11785 mmol. - gewichtsregulierung - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - soluzione iniettabile in penna preriempita - semaglutidum 2.4 mg, dinatrii phosphas dihydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 0.11785 mmol. - gewichtsregulierung - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - soluzione iniettabile in penna preriempita - semaglutidum 0.25 mg, dinatrii phosphas dihydricus, propylenglycolum, phenolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.37 ml corresp. natrium 0.136 mg. - gewichtsregulierung - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - soluzione iniettabile in penna preriempita - semaglutidum 0.5 mg, dinatrii phosphas dihydricus, propylenglycolum, phenolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.37 ml corresp. natrium 0.136 mg. - gewichtsregulierung - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

novo nordisk pharma ag - semaglutidum - soluzione iniettabile in penna preriempita - semaglutidum 1 mg, dinatrii phosphas dihydricus, propylenglycolum, phenolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 0.275 mg. - gewichtsregulierung - biotechnologika